DEXCOM, INC. Paid-in-Kind Interest
DEXCOM, INC. (DXCM) reported Paid-in-Kind Interest of $2.00 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:PaidInKindInterest · last filed 2026-07-30
- DEXCOM, INC. paid-in-kind interest for the quarter ending 2026-06-30 was $1.00M, a 44.44% decline year-over-year.
- DEXCOM, INC. paid-in-kind interest for the quarter ending 2026-03-31 was $1.00M, a 47.37% decline year-over-year.
- DEXCOM, INC. paid-in-kind interest for the quarter ending 2025-12-31 was $1.70M, a 10.53% decline year-over-year.
- DEXCOM, INC. paid-in-kind interest for the quarter ending 2025-09-30 was $1.90M, a 0.00% change year-over-year.
- DEXCOM, INC. paid-in-kind interest for fiscal 2025 was $7.30M, a 2.67% decline from fiscal 2024.
- DEXCOM, INC. paid-in-kind interest for fiscal 2024 was $7.50M, a 3.85% decline from fiscal 2023.
- DEXCOM, INC. paid-in-kind interest for fiscal 2023 was $7.80M, a 23.81% increase from fiscal 2022.
- DEXCOM, INC. paid-in-kind interest for fiscal 2022 was $6.30M, a 12.50% decline from fiscal 2021.
| Period end | Paid-in-Kind Interest 3 month | Paid-in-Kind Interest 6 month | Paid-in-Kind Interest 9 month | Paid-in-Kind Interest 12 month | Paid-in-Kind Interest 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | $1.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $2.00M 10-Q · filed 2026-07-30 | $3.70M derived: sum of 3 quarters · filed 2026-07-30 | $5.60M derived: sum of 4 quarters · filed 2026-07-30 | |
| 2026-03-31 | $1.00M 10-Q · filed 2026-04-30 | $2.70M derived: sum of 2 quarters · filed 2026-04-30 | $4.60M derived: sum of 3 quarters · filed 2026-04-30 | $6.40M derived: sum of 4 quarters · filed 2026-07-30 | |
| 2025-12-31 | $1.70M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $3.60M derived: sum of 2 quarters · filed 2026-02-12 | $5.40M derived: sum of 3 quarters · filed 2026-07-30 | $7.30M 10-K · filed 2026-02-12 | |
| 2025-09-30 | $1.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $3.70M derived: sum of 2 quarters · filed 2026-07-30 | $5.60M 10-Q · filed 2025-10-30 | $7.50M derived: sum of 4 quarters · filed 2026-07-30 | |
| 2025-06-30 | $1.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $3.70M 10-Q · filed 2026-07-30 | $5.60M derived: sum of 3 quarters · filed 2026-07-30 | $7.50M derived: sum of 4 quarters · filed 2026-07-30 | |
| 2025-03-31 | $1.90M 10-Q · filed 2026-04-30 | $3.80M derived: sum of 2 quarters · filed 2026-04-30 | $5.70M derived: sum of 3 quarters · filed 2026-04-30 | $7.50M derived: sum of 4 quarters · filed 2026-04-30 | |
| 2024-12-31 | $1.90M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $3.80M derived: sum of 2 quarters · filed 2026-02-12 | $5.60M derived: sum of 3 quarters · filed 2026-02-12 | $7.50M 10-K · filed 2026-02-12 | |
| 2024-09-30 | $1.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $3.70M derived: sum of 2 quarters · filed 2025-10-30 | $5.60M 10-Q · filed 2025-10-30 | $7.60M derived: sum of 4 quarters · filed 2026-02-12 | |
| 2024-06-30 | $1.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-30 | $3.70M 10-Q · filed 2025-07-30 | $5.70M derived: sum of 3 quarters · filed 2026-02-12 | $7.90M derived: sum of 4 quarters · filed 2026-02-12 | |
| 2024-03-31 | $1.90M 10-Q · filed 2025-05-01 | $3.90M derived: sum of 2 quarters · filed 2026-02-12 | $6.10M derived: sum of 3 quarters · filed 2026-02-12 | $8.20M derived: sum of 4 quarters · filed 2026-02-12 | |
| 2023-12-31 | $2.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $4.20M derived: sum of 2 quarters · filed 2026-02-12 | $6.30M derived: sum of 3 quarters · filed 2026-02-12 | $7.80M 10-K · filed 2026-02-12 | |
| 2023-09-30 | $2.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-24 | $4.30M derived: sum of 2 quarters · filed 2024-10-24 | $5.80M 10-Q · filed 2024-10-24 | $7.40M derived: sum of 4 quarters · filed 2025-02-18 | |
| 2023-06-30 | $2.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-25 | $3.60M 10-Q · filed 2024-07-25 | $5.20M derived: sum of 3 quarters · filed 2025-02-18 | $6.70M derived: sum of 4 quarters · filed 2025-02-18 | |
| 2023-03-31 | $1.50M 10-Q · filed 2024-04-25 | $3.10M derived: sum of 2 quarters · filed 2025-02-18 | $4.60M derived: sum of 3 quarters · filed 2025-02-18 | $6.20M derived: sum of 4 quarters · filed 2025-02-18 | |
| 2022-12-31 | $1.60M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-18 | $3.10M derived: sum of 2 quarters · filed 2025-02-18 | $4.70M derived: sum of 3 quarters · filed 2025-02-18 | $6.30M 10-K · filed 2025-02-18 | |
| 2022-09-30 | $1.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-26 | $3.10M derived: sum of 2 quarters · filed 2023-10-26 | $4.70M 10-Q · filed 2023-10-26 | $6.10M derived: sum of 4 quarters · filed 2024-02-08 | |
| 2022-06-30 | $1.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-27 | $3.20M 10-Q · filed 2023-07-27 | $4.60M derived: sum of 3 quarters · filed 2024-02-08 | $6.20M derived: sum of 4 quarters · filed 2024-02-08 | |
| 2022-03-31 | $1.60M 10-Q · filed 2023-04-27 | $3.00M derived: sum of 2 quarters · filed 2024-02-08 | $4.60M derived: sum of 3 quarters · filed 2024-02-08 | $6.70M derived: sum of 4 quarters · filed 2024-02-08 | |
| 2021-12-31 | $1.40M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-08 | $3.00M derived: sum of 2 quarters · filed 2024-02-08 | $5.10M derived: sum of 3 quarters · filed 2024-02-08 | $7.20M 10-K · filed 2024-02-08 | $88.70M 10-K · filed 2022-02-14 |
| 2021-09-30 | $1.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-27 | $3.70M derived: sum of 2 quarters · filed 2022-10-27 | $5.80M 10-Q · filed 2022-10-27 | ||
| 2021-06-30 | $2.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-28 | $4.20M 10-Q · filed 2022-07-28 | |||
| 2021-03-31 | $2.10M 10-Q · filed 2022-04-28 | ||||
| 2020-12-31 | $7.00M 10-K · filed 2023-02-09 | $74.00M 10-K · filed 2021-02-11 | |||
| 2019-12-31 | $49.60M 10-K · filed 2022-02-14 | ||||
| 2018-12-31 | $17.90M 10-K · filed 2021-02-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |